More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

Phosphagenics Expands Licence Agreement for Diclofenac Gel

May 18, 2016 at 5:03 AM EDT · Issued by Avecho Biotechnology Limited

Filed with ASX · May 18, 2016 at 5:03 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/phosphagenics-expands-licence-agreement-for-diclofenac-gel

Avecho Biotechnology Limited on 6ix

Story so far

  • TPM/Diclofenac Gel - Themis in Supply Agmt with NovartisMar 30, 2016
  • Phosphagenics Licenses Diclofenac Gel for Indian MarketFeb 11, 2016

Earlier from Avecho Biotechnology

  • Phosphagenics Expands Japanese Option to Oxycodone PatchMay 17, 2016
  • Phosphagenics Signs Japanese License Option and R&D AllianceApr 29, 2016
  • Successful Results -Phase 2 TPM Trentinoin Gel Study on AcneMar 30, 2016
  • Response to an ASX Price QueryMar 30, 2016
  • Positive Results Phase 1B Study Transdermal Oxycodone PatchMar 30, 2016

Later from Avecho Biotechnology

  • Phosphagenics Initiates Cattle StudyJun 1, 2016
  • Phosphagenics Completes Grower/Finisher Pig StudyJun 29, 2016
  • June 2016 Half-year Financial Report and Appendix 4DAug 25, 2016
  • Phosphagenics Begins Feed Efficiency Study in PoultryAug 31, 2016
  • Phosphagenics Updates Long Term Incentive SchemeSep 11, 2016
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer